Regulatory affairs
This entire item is of approximately 350 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the November 2007 issue of Biomedical Materials and download it online

  • Issue: November 2007, page: 8

    ReGen product rebuffed by US regulatory authorities

    Orthopaedic company ReGen Biologics Inc said it has failed in its latest bid to gain approval from the US Food and Drug Administration (FDA) for its collagen scaffold matrix with a range of applications.

    Read related items on:

          
  • Medical
  • CMI
  • Legal and regulatory
  • ReGen Biologics

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact